{
  "url": "https://openlegislation.uk/eu-directive-1993-42/annex-V/division-3/division-3.1",
  "json_url": "https://openlegislation.uk/eu-directive-1993-42/annex-V/division-3/division-3.1.json",
  "legislation": "eudr/1993/42",
  "legislation_title": "Council Directive 93/42/EEC of 14 June 1993 concerning medical devices",
  "legislation_url": "https://openlegislation.uk/eu-directive-1993-42",
  "path": "annex/V/division/3/division/3.1",
  "kind": "division",
  "number": "3.1",
  "heading": null,
  "text": "The manufacturer must lodge an application for assessment of his quality system with a notified body.\nThe application must include:\nthe name and address of the manufacturer,\nall the relevant information on the product or product category covered by the procedure,\na written declaration that no application has been lodged with any other notified body for the same products,\nthe documentation on the quality system,\nan undertaking to fulfil the obligations imposed by the quality system is approved,\nan undertaking to maintain the practicability and effectiveness of the approved quality system,\nwhere appropriate, the technical documentation on the types approved and a copy of the EC type-examination certificates,\nan undertaking by the manufacturer to institute and keep up to date a systematic procedure to review experience gained from devices in the post-production phase, including the provisions referred to in Annex X, and to implement appropriate means to apply any necessary corrective action. This undertaking must include an obligation for the manufacturer to notify the competent authorities of the following incidents immediately on learning of them:\n(i) any malfunction or deterioration in the characteristics and/or performance of a device, as well as any inadequacy in the labelling or the instructions for use which might lead to or might have led to the death of a patient or user or to a serious deterioration in his state of health;\n(ii) any technical or medical reason connected with the characteristics or performance of a device for the reasons referred to in subparagraph (i) above leading to a systematic recall of devices of the same type by the manufacturer.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Substituted by Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market (Text with EEA relevance)."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/1993/42/annex/V/division/3/division/3.1",
    "retrieved_at": "2026-11-01T15:23:18.816106+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}